How to use Technologies searched

A search for a company looking for a cancer, preclinical stage, synthetic opportunity would use the selection "Biomedicine, Diagnostics" in 'Sector', 'Cancerous, neoplasmatic' in 'Disease Category', 'Drugs, Small Molecule' in 'Technology' and 'Preclinical' in 'Development Stage'.

Selection of 'Enabling Technology, Platform technology' in 'Sector' will identify all kinds of searches for technologies that can be used in more areas of life sciences than pharmaceuticals only.

Each search profile gives the name or a short description of the company behind the search, and a link allowing to contact your potential licensee.

Registered users can create non-public notifications profiles which will inform them about new Technologies Searched entries fitting their expertise as specified. In addition these profiles allow them to filter the available information more comfortably.


CPRI is searching opportunities in oncology, diabetes and CNS

Organization name

Chongqing Pharmaceutical Research Institute Co., Ltd. (CPRI)


Chongqing Pharmaceutical Research Institute Co., Ltd. (CPRI) is a fast growing research-based & client-oriented enterprise engaged in:

  • Pharmaceutical R&D services
  • Early stage process development
  • cGMP manufacturing of APIs & advanced intermediates

Primary therapeutic area(s) are:

  • Neoplasms / cancer / oncology
  • Endocrine, nutritional and metabolic diseases
  • Mental and behavioural disorders
  • Diseases of the nervous system
  • Cardiovascular
  • Skin and subcutaneous tissue

CPRI is actively seeking potential opportunities in co-developing proprietary early-stage compounds/formulations (ready for IND) for the China market in

  • anti-tumor
  • anti-diabetes¬†
  • central nervous system areas

To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login Register

Your feedback

Please click here to log in to view the complete profile.


latest entries